Docetaxel followed by epirubicin plus docetaxel as primary systemic therapy for large operable breast cancer

被引：0
|
作者：
Frutuoso, Cristina [1 ]
Henriques, Isabel [2 ]
Pazos, Isabel [3 ]
Abraul, Elsa [1 ]
Pego, Antonio [3 ]
Belo, Joana [2 ]
Campos, Ondina [2 ]
Gervasio, Helena [3 ]
De Oliveira, Carlos F. [1 ]
机构：
[1] Hosp Univ Coimbra, Serv Ginecol, Coimbra, Portugal
[2] Maternidade Bissaya Berreto, Serv Ginecol, Coimbra, Portugal
[3] Ctr Reg Oncol Coimbra, Coimbra, Portugal
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [1] Primary chemotherapy with sequential docetaxel followed by docetaxel and epirubicin in large operable breast cancer
    Frutuoso, C.
    Henriques, I.
    Pazos, I.
    Abraul, E.
    Pego, A.
    Belo, J.
    Campos, O.
    Gervasio, H.
    De Oliveira, C.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2007, 28 (06) : 447 - 450
  • [2] Primary systemic chemotherapy for operable breast cancer with docetaxel followed by cyclophosphamide, epirubicin, and fluorauracil (DOC-CEF)
    Kikawa, Y.
    Masai, Y.
    Hashimoto, T.
    Nakamoto, Y.
    Nishikawa, H.
    Takahara, S.
    Suwa, H.
    Tachibana, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Epirubicin and Cyclophosphamide Followed by Docetaxel as Primary Systemic Chemotherapy in Locally Advanced Breast Cancer
    Hirano, Akira
    Shimizu, Tadao
    Watanabe, Osamu
    Kinoshita, Jun
    Kimura, Kiyomi
    Kamimura, Mari
    Domoto, Kaoru
    Aiba, Motohiko
    Ogawa, Kenji
    [J]. ANTICANCER RESEARCH, 2008, 28 (6B) : 4137 - 4142
  • [4] A feasibility study of docetaxel in combination with anthracycline and cyclophosphamide or docetaxel followed by anthracycline plus cyclophosphamide in adjuvant therapy for operable breast
    Shen, ZZ
    Liu, GY
    Shao, ZM
    Wang, SM
    Zhang, B
    Jiang, ZF
    He, PQ
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S107 - S107
  • [5] Primary systemic therapy using docetaxel/cyclophosphamide/bevacizumab (TCB) followed by doxorubicin (A) in operable or locally advanced breast cancer (BC)
    Makhoul, I.
    Klimberg, S.
    Henry-Tillman, R.
    Westbrook, K.
    Korourian, S.
    Siegel, E.
    Hutchins, L.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 592 - 593
  • [6] Primary systemic therapy using docetaxel/cyclophosphamide/bevacizumab (TCB) followed by doxorubicin (A) in operable or locally advanced breast cancer (BC)
    Makhoul, I
    Klimberg, S.
    Henri-Tillmen, R.
    Westbrook, K.
    Hutchins, L.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S224 - S225
  • [7] Epirubicin/cyclophosphamide followed by docetaxel as the primary systemic therapy for locally advanced breast cancer: The final analysis of a phase II study
    Hirano, Akira
    Kamimura, Mari
    Ogura, Kaoru
    Hattori, Akinori
    Okubo, Fumie
    Inoue, Hiroaki
    Kinoshita, Jun
    Fujibayashi, Mariko
    Shimizu, Tadao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Results of clinical endpoints of a randomized phase It trial with doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as primary systemic therapy for early breast cancer
    Schneeweiss, A.
    Ruiz, A.
    Rovira, P.
    Bottini, A.
    Manikhas, A.
    Wacker, J.
    Schumacher, T.
    Wolf, M.
    Segui, M.
    Sinn, P.
    Kennedy, L.
    Mansouri, K.
    Bauknecht, T.
    [J]. BREAST, 2009, 18 : S63 - S63
  • [9] Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study
    Martin, Miguel
    Ruiz Simon, Amparo
    Ruiz Borrego, Manuel
    Ribelles, Nuria
    Rodriguez-Lescure, Alvaro
    Munoz-Mateu, Montserrat
    Gonzalez, Sonia
    Margeli Vila, Mireia
    Barnadas, Agusti
    Ramos, Manuel
    Del Barco Berron, Sonia
    Jara, Carlos
    Calvo, Lourdes
    Martinez-Janez, Noelia
    Mendiola Fernandez, Cesar
    Rodriguez, Cesar A.
    Martinez de Duenas, Eduardo
    Andres, Raquel
    Plazaola, Arrate
    de la Haba-Rodriguez, Juan
    Manuel Lopez-Vega, Jose
    Adrover, Encarna
    Isabel Ballesteros, Ana
    Santaballa, Ana
    Sanchez-Rovira, Pedro
    Baena-Canada, Jose M.
    Casas, Maribel
    del Carmen Camara, Mara
    Maria Carrasco, Eva
    Lluch, Ana
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) : 3788 - +
  • [10] Docetaxel Followed by Fluorouracil/Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy for Patients with Primary Breast Cancer
    Iwata, Hiroji
    Sato, Nobuaki
    Masuda, Norikazu
    Nakamura, Seigo
    Yamamoto, Naohito
    Kuroi, Katsumasa
    Kurosumi, Masafumi
    Tsuda, Hitoshi
    Akiyama, Futoshi
    Ohashi, Yasuo
    Toi, Masakazu
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 867 - 875
12345